Australia markets open in 1 hour 20 minutes

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.56-0.27 (-0.63%)
At close: 04:00PM EDT
41.60 -0.96 (-2.26%)
After hours: 05:13PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close42.83
Open42.73
Bid41.60 x 1300
Ask42.45 x 3100
Day's range42.00 - 43.14
52-week range34.86 - 44.75
Volume4,040,583
Avg. volume2,457,037
Market cap28.693B
Beta (5Y monthly)0.37
PE ratio (TTM)31.09
EPS (TTM)1.37
Earnings date09 Aug 2022 - 15 Aug 2022
Forward dividend & yield0.76 (1.93%)
Ex-dividend date19 May 2022
1y target est52.44
  • GlobeNewswire

    Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

    NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022 at 2:20 p.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/news-and-events/events. The webcast will also be archived for a minimum of thirty days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of bio

  • Simply Wall St.

    Royalty Pharma plc's (NASDAQ:RPRX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

    It is hard to get excited after looking at Royalty Pharma's (NASDAQ:RPRX) recent performance, when its stock has...

  • GlobeNewswire

    Royalty Pharma to Present at the UBS Global Healthcare Conference 2022

    NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the UBS Global Healthcare Conference 2022 on May 24, 2022 at 1:15 p.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/news-and-events/events. The webcast will also be archived for a minimum of thirty days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical roya